Results 1 to 10 of about 6,842,005 (300)

Efferocytosis and Respiratory Disease

International Journal of Molecular Sciences, 2023
Cells are the smallest units that make up living organisms, which constantly undergo the processes of proliferation, differentiation, senescence and death. Dead cells need to be removed in time to maintain the homeostasis of the organism and keep it healthy. This process is called efferocytosis.
Guoqiang Wang, Xu Zuo, Fang Wang
exaly   +3 more sources

Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [PDF]

, 2020
Background: Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma.
Soriano, Joan B., GBD Chronic Respiratory Disease Collaborators, Violante FS   +2 more
core   +6 more sources

Respiratory muscles dysfunction and respiratory diseases [PDF]

Terapevticheskii arkhiv, 2019
This review presents an analysis of the literature on the topic of respiratory muscle (RM) dysfunction in various forms of respiratory pathology: chronic obstructive pulmonary disease (COPD), asthma, community-acquired pneumonia, idiopathic pulmonary fibrosis (IPF), sarcoidosis and interstitial lung diseases (ILD), associated with systemic connective ...
B I Geltser, I G Kurpatov, A A Dej, A G Kozhanov   +3 more
openaire   +3 more sources

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma

Respiratory Research, 2022
Background Whether cysteinyl-leukotriene receptor antagonists (LTRAs) have a similar antitussive effect to inhaled corticosteroids and long-acting β2-agonist (ICS/LABA), and that LTRA plus ICS/LABA is superior to LTRAs alone or ICS/LABA alone in treating
Fang Yi, Chen Zhan, Baojuan Liu, Hu Li, Jianmeng Zhou, Jiaman Tang, Wen Peng, Wei Luo, Qiaoli Chen, Kefang Lai   +9 more
doaj   +1 more source

Obesity and respiratory diseases [PDF]

Chronic Respiratory Disease, 2008
Obesity is a worldwide epidemic and is known to increase the risk of cardiovascular disease, type 2 diabetes, and certain forms of cancer. In addition, obesity is now recognized as an important risk factor in the development of several respiratory diseases.
A T, Murugan, G, Sharma
openaire   +2 more sources

Diagnostic procedure for idiopathic eosinophilic pleural effusion: a single-center experience

BMC Pulmonary Medicine, 2020
Background Eosinophilic pleural effusion (EPE) is attributed to several well-recognised causes. However, some patients remain idiopathic, even after thorough clinical work-up.
Weizhan Luo, Yunxiang Zeng, Panxiao Shen, Jianxing He, Jinlin Wang   +4 more
doaj   +1 more source

The impact of the COVID‐19 pandemic on the care of pulmonary hypertension patients outside the Hubei province in China

Pulmonary Circulation, 2022
The Coronavirus disease 2019 (COVID‐19) pandemic has severely affected the lives of people around the world, especially some patients with severe chronic diseases.
Yuqin Chen, Bihua Zhong, Qian Jiang, Yilin Chen, Wenjun He, Ning Lai, Dansha Zhou, Jiahao He, Yiting Yao, Yi Shen, Juan Li, Jianuo Yang, Zhe Zhang, Ran Ma, Jian Wang, Chunli Liu   +15 more
doaj   +1 more source

Clinical outcomes and survival following lung transplantation for work-related lung disease: a single-center retrospective cohort study

Journal of Occupational Medicine and Toxicology, 2023
Background Patients with work-related lung disease (WRLD) are at increased risk of death caused by severe lung tissue damage and fibrosis. This study aimed to assess the clinical outcomes of lung transplantation (LTx) for WRLD and compare the results of ...
Chunrong Ju, Yalan Yang, Qiaoyan Lian, Lulin Wang, Xiaohua Wang, Bing Wei, Danxia Huang, Xin Xu, Jianxing He   +8 more
doaj   +1 more source

Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

Frontiers in Oncology, 2021
BackgroundCheckpoint inhibitor-related pneumonitis (CIP) is a potentially fatal immune-related adverse event that occurs during treatment with immune checkpoint inhibitors (ICIs).
Xinqing Lin, Haiyi Deng, Yilin Yang, Jianhui Wu, Guihuan Qiu, Suyang Li, Xiaohong Xie, Ming Liu, Zhanhong Xie, Yinyin Qin, Yong Song, Chengzhi Zhou   +11 more
doaj   +1 more source

Systems for the management of respiratory disease in primary care - an international series: United Kingdom [PDF]

, 2010
INTRODUCTION: The UK National Health Service (NHS) is essentially publicly funded through general taxation. Challenges facing the NHS include the rise in prevalence of long-term conditions and financial pressures.
Allison Worth, Mark Levy, Worth, Allison, Levy, Mark L., Fletcher, Monica, Pinnock, Hilary, Aziz Sheikh, Monica Fletcher, Hilary Pinnock, Pinnock, Hilary; id_orcid, Hoskins, Gaylor, Levy, Mark, Gaylor Hoskins, Sheikh, Aziz, Levy, Mark L   +14 more
core   +1 more source